This is the authors' abstract. We don't add key points for this paper.
A series of new squaramide‐based organocatalysts were synthesized from commercially available 3,4‐dimethoxycyclobut‐3‐ene‐1,2‐dione in two steps. A 2.5 mol‐% loading of the organocatalyst successfully catalyzed the asymmetric allylation of isatins with allyltributyltin to give the corresponding 3‐allyl‐3‐hydroxyoxindoles in high yields and enantioselectivities (up to 98 % ee).
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: